Active Ingredient: MESORIDAZINE BESYLATE
Proprietary Name: SERENTIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 25MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N016775
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information